THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
D000818:Animals; D000970:Antineoplastic Agents; D001375:Azaguanine; D002286:Carcinoma, Ehrlich Tumor; D003348:Cortisone; D003520:Cyclophosphamide; D003609:Dactinomycin; D008466:Mechlorethamine; D051379:Mice; D016685:Mitomycin; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental; D010600:Pharmacology; D012106:Research; D012509:Sarcoma; D012517:Sarcoma, Yoshida; D013852:Thiotepa; D014116:Toxicology
D000970:Antineoplastic Agents; D003609:Dactinomycin; D008466:Mechlorethamine; D016685:Mitomycin; D003520:Cyclophosphamide; D013852:Thiotepa; D001375:Azaguanine; D003348:Cortisone
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; AZAGUANINE; CARCINOMA, EHRLICH TUMOR; CORTISONE; CYCLOPHOSPHAMIDE; EXPERIMENTAL LAB STUDY; MECHLORETHAMINE; MICE; MITOMYCIN; NEOPLASM IMMUNOLOGY; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; SARCOMA, YOSHIDA; THIO-TEPA; TOXICOLOGIC REPORT